^
Association details:
| Biomarker: | AMHR2 expression |
|---|---|
| Cancer: | Colorectal Cancer |
| Drug: | murlentamab (GM102) (AMHR2 antagonist) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer
Published date:
04/07/2021
Excerpt:
...treating AMHRII-expressing tumors with an anti-AMHRII selective agent such as murlentamab, also named 3C23K or GM102…antitumor activity of murlentamab against AMHRII-expressing colorectal cancer and hepatocarcinoma Patient-Derived tumor Xenografts (PDX) models.
DOI:
10.3390/biology10040305
